Focused Investment, Partners, LLC has filed an application seeking minor site plan approval for 136 Harding Avenue in Bellmawr. The applicant proposes to convert an existing 7,537 square foot building into Building #4 for medical cannabis grow and cultivation facility with 19 parking spaces, according to a recently published Legal Notice. The facility will be used to grow and cultivate cannabis plants for distribution by online medical marijuana vendors such as https://www.greensociety.ca/ and many others. Take note that this will only grow and maintain plants and produce medical cannabis items and not actually becoming a cannabis dispensary. With this being said, if you are looking to open up a dispensary (if legal where you are) and the idea of growing your own products sounds like something you want to try, maybe knowing that by having equipment like Rosin Press at hand, this process may run a lot more smoothly than you may think.
Variances and waivers will be requested during the Planning Board meeting, which has been scheduled for Monday, August 5, 2019 at 7:00 p.m. in the Bellmawr Borough Hall.
The application and any other supporting documents are on file with the Board Secretary and available for inspection during regular business hours, Monday through Friday (except legal holidays) prior to the hearing.
In May, 2018, Curaleaf announced that the Bellmawr dispensary is the largest on the East Coast.
Designated as designated as Block 61, Lot 8, 136 Harding Avenue was formerly known as Block 61, Lot 8.01 and was consolidated in 2018 with Block 61, Lot 8, 111 Coolidge Avenue, and is located in the Light Industrial Zone. It last sold for $750,000.00 in November, 2018.
While doing research for this story, we learned from Mark Matthews of 42 Freeway that there is some interesting background on this property.
In the 1980’s, the 136 Harding Avenue address was used by former musician, Richard Marcus, for his “Crazy Richard’s” peanut butter.
The property was also once the address of Truxton, Inc., a pharmaceutical and medical supplier, and a family owned business since 1957.
In early, 2017, a “labeling error” traced back to Truxton, Inc. lead to a national FDA recall of Phenobarbital, a drug prescribed to young children and pets to treat epilepsy.